Abstract

Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adults with refractory and super-refractory SE has been shown to be feasible and effective. Methods: We describe our experience, including the challenges of achieving and maintaining ketosis, in an adult with new onset refractory status epilepticus (NORSE). Case Vignette: A previously healthy 29-year-old woman was admitted with cryptogenic NORSE following a febrile illness; course was complicated by prolonged super-refractory SE. A comprehensive work-up was notable only for mild cerebral spinal fluid (CSF) pleocytosis, elevated nonspecific serum inflammatory markers, and edematous hippocampi with associated diffusion restriction on magnetic resonance imaging (MRI). Repeat CSF testing was normal and serial MRIs demonstrated resolution of edema and diffusion restriction with progressive hippocampal and diffuse atrophy. She required prolonged therapeutic coma with high anesthetic infusion rates, 16 antiseizure drug (ASD) trials, empiric immunosuppression and partial bilateral oophorectomy. Enteral ketogenic formula was started on hospital day 28. However, sustained beta-hydroxybutyrate levels >2 mmol/L were only achieved 37 days later following a comprehensive adjustment of the care plan. KD was challenging to maintain in the intensive care unit (ICU) and was discontinued due to poor nutritional state and pressure ulcers. KD was restarted again in a non-ICU unit facilitating ASD tapering without re-emergence of SE. Discussion: There are inconspicuous carbohydrates in commonly administered medications for SE including antibiotics, electrolyte repletion formulations, different preparations of the same drug (i.e., parenteral, tablet, or suspension) and even solutions used for oral care―all challenging the use of KD in the hospitalized patient. Tailoring comprehensive care and awareness of possible complications of KD are important for the successful implementation and maintenance of ketosis.

Highlights

  • Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach

  • Our patient was initially started on ketogenic diet (KD) on hospital day 28 (HD 28) with a goal of 5:1 ratio (KetoCal® 4:1 at 55 mL/h plus 33 mL medium-chain triglycerides (MCT) oil to balance carbohydrate intake from medications, documented as 51 g daily on HD 30)

  • We suggest that ketamine be considered as an alternative to pentobarbital in patients with status epilepticus on KD, given their lack of propylene glycol [46], This same concept can be applied for phenytoin (Dilantin® 50 mg/mL), which contains 40% propylene glycol [42] amounting to a carbohydrate content of 414 mg

Read more

Summary

Introduction

Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. The implementation of ketogenic diet (KD) in adults with refractory and super-refractory SE has been shown to be feasible and potentially effective [1,2,3,4,5]. Most often used in childhood epilepsies, KD has emerged as a potential adjunctive treatment for pediatric SE [6,7]. We describe our experience with an adult with new onset refractory status epilepticus (NORSE) focusing on the unexpected challenge of achieving and maintaining ketosis. A comprehensive review of factors potentially jeopardizing ketosis commonly encountered in the critical care setting and alternatives are provided

Presentation
Question
Ketogenic Diet
10. Hidden Carbohydrates Can Hinder Achievement of Ketosis
11. Noncarbohydrate Related Hindrance of Ketosis
12. Question
KD maintenance
Pitfalls to consider
13. Question
15. Question
16. KD and Supplements Question
17. Termination of Ketotic Therapy Question
Findings
18. Anticipating and Managing Complications Question
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call